Clinical Trial Update: Dose Reduction of Lopinavir in Children [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating dosing: dose reduction of Lopinavir in children with HIV infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Lopinavir (lopinavir)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: HIV Infections | Phase 2 | Status: COMPLETED